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The scaffold protein X-ray repair cross-complementing 1
(XRCC1) interacts withmultiple enzymes involved inDNAbase
excision repair and single-strand break repair (SSBR) and is
important for genetic integrity and normal neurological func-
tion. One of the most important interactions of XRCC1 is that
with polynucleotide kinase/phosphatase (PNKP), a dual-func-
tion DNA kinase/phosphatase that processes damaged DNA
termini and that, if mutated, results in ataxia with oculomotor
apraxia 4 (AOA4) and microcephaly with early-onset seizures
and developmental delay (MCSZ). XRCC1 and PNKP interact
via a high-affinity phosphorylation-dependent interaction site
inXRCC1 and a forkhead-associated domain in PNKP.Here, we
identified using biochemical and biophysical approaches a sec-
ond PNKP interaction site in XRCC1 that binds PNKP with
lower affinity and independently of XRCC1 phosphorylation.
However, this interaction nevertheless stimulated PNKP activ-
ity and promoted SSBR and cell survival. The low-affinity inter-
action site required the highly conserved Rev1-interacting
region (RIR) motif in XRCC1 and included three critical and evo-
lutionarily invariant phenylalanine residues. We propose a bipar-
tite interactionmodel inwhichthepreviously identifiedhigh-affin-
ity interaction acts as a molecular tether, holding XRCC1 and
PNKPtogether and therebypromoting the low-affinity interaction
identified here, which then stimulates PNKP directly.
XRCC1 is a molecular scaffold protein that interacts with
multiple components of the single-strand break repair (SSBR)4
pathway including DNA polymerase  (Pol ) (1, 2), polynucle-
otide kinase/phosphatase (PNKP) (3, 4), Aprataxin (APTX) (5,
6), Aprataxin- and PNKP-like factor (7–9), and DNA ligase 3
(Lig3) (10, 11). XRCC1 also interacts with poly(ADP-ribose),
the product of PARP1 and/or PARP2 activity, via its central
BRCT1 domain, thereby enabling its accumulation at chromo-
somal SSBs (12–16). The interactions mediated by XRCC1
affect protein partners in several ways including stabilization,
recruitment to sites of SSBs, and in some cases enzymatic stim-
ulation. One of the most important interactions mediated by
XRCC1 is with PNKP, because many of the DNA strand breaks
arising in cells are substrates for this enzyme (17–21). PNKP
possesses both DNA 5-kinase and DNA 3-phosphatase activ-
ities, which together convert 5-hydroxyl and 3-phosphate ter-
mini to canonical 5-phosphate and 3-hydroxyl moieties,
respectively, thereby enabling the final steps of DNA gap filling
and DNA ligation (22–24).
The importance of PNKP is illustrated by the observation
thatmutations in this gene result in the hereditary neurological
diseases microcephaly with early onset seizures (MCSZ) and
ataxia oculomotor apraxia 4 (AOA4) (25–27). MCSZ is char-
acterized by neurodevelopment defects and reduced cerebellar
size, whereas AOA4 is characterized by progressive cerebellar
degeneration and ataxia. It is unclear why mutations in the
same protein can result in two different neurological diseases
but this may reflect the varying impact of the different muta-
tions on PNKP function and/or the additional role of this pro-
tein in non-homologous end joining. None of the mutations, to
date, result in the complete absence of enzyme activity, suggest-
ing that PNKP may be essential for viability (28). Consistent
with this idea, germ line deletion of PNKP is lethal in mouse
(29).
XRCC1 interacts with PNKP by both phosphorylation-de-
pendent and phosphorylation-independent mechanisms (3, 4,
30). The phosphorylation-dependent interaction is mediated
by a forkhead-associated (FHA) domain in PNKP and a cluster
of three CK2 phosphorylation sites at Ser518/Thr519/Thr523 in
XRCC1, resulting in a very high-affinity interaction with full-
length phosphorylated XRCC1 (Kd  3.5 nM) (4, 30, 31).
XRCC1 stimulates PNKP activity at limiting concentrations of
the latter (3, 4), in part at least by displacing PNKP from its
substrate and thereby releasing the enzyme for additional
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cycles of activity (30, 32). However, whereas the phosphoryla-
tion-dependent interaction contributes to PNKP stimulation it
is not essential for this purpose, because non-phosphorylated
XRCC1 can also stimulate PNKP to a lesser extent (3, 32, 33).
Consistent with this, full-length XRCC1 contains a second
binding site that mediates a lower affinity, phosphorylation-
independent, interaction (Kd  30 nM) with the catalytic
domain of PNKP (3, 32, 33). However, the location and physi-
ological importance of this binding site in XRCC1 are
unknown. Given the importance of XRCC1 and PNKP for nor-
mal neurological function in mouse and man (25, 29, 34) we
have identified in this work the location and importance of the
low-affinity binding site in XRCC1.
Results
XRCC1 is a scaffold protein comprised ofmultiplemolecular
interaction domains (Fig. 1A). Although binding partners for
most of these domains have been identified, XRCC1 also pos-
sesses a poorly characterized but highly conserved region
denoted the “Rev1-interacting region” (RIR) located just
upstream of the BRCT1 domain (35). Of particular interest
within this region is a cluster of conserved residues that
includes the invariant phenylalanine residues Phe173, Phe191,
and Phe192 (Fig. 1). To examine the importance of this region,
we mutated the three conserved phenylalanine residues to ala-
nine and examined the mutated protein (denoted XRCC1-
HisFFF) for ability to complementXRCC1-mutant EM9Chinese
hamster ovary (CHO) cells. XRCC1-HisFFF was unable to
restore normal levels of cell survival in EM9 cells following
treatment with H2O2 (Fig. 2A). However, this was not the case
following methyl methanesulfonate (MMS) treatment, to
which EM9 cells expressing either XRCC1-His or XRCC1-
HisFFF exhibited similar levels of sensitivity over the concentra-
tion range employed (Fig. 2B). In agreement with these data,
XRCC1-HisFFF was less able to support normal rates of SSBR
than XRCC1-His following H2O2 treatment (Fig. 3A), but was
equally able to support normal rates of base excision repair
following treatment with MMS (Fig. 3B). The ability of the
mutated protein to complement phenotypes associated with
MMS-induced damage, but not H2O2-induced damage, sug-
gests that this mutation does not disrupt general folding of the
protein. Rather these data suggest that the triple phenylalanine
mutation is a separation-of-functionmutation that impedes the
repair of DNA strand breaks induced at sites of DNA oxidation
but not those induced at sites of DNA alkylation.
One possible explanation for the selective impact of the phe-
nylalanine mutations is that they disrupt the interaction of
XRCC1 with PNKP. This is because although PNKP is pre-
dicted to play a minor role in the repair of MMS-induced DNA
breaks, it is predicted to play a major role in the repair of oxi-
dative DNA breaks (20). The high-affinity interaction of
XRCC1 with PNKP is mediated by the phosphorylated CK2
sites located at Ser518/Thr519/Thr523, but the site of the low-
affinity interaction is unclear. The latter interaction is far
weaker than the phosphorylation-dependent interaction but is
nevertheless important for PNKP stimulation (3, 4, 30). To
examine whether the phenylalanine motif might mediate
the phosphorylation-independent interaction we examined
recombinant histidine-tagged XRCC1 purified from Esche-
richia coli for interaction with an enzymatically active deriva-
tive of PNKP labeled with acrylodan (denoted PNKP-AC) in
fluorescence quenching experiments. For these experiments
we employed full-length XRCC1-His and His-XRCC1161–406, a
truncated derivative of XRCC1 encoding the central 245 amino
acids spanning the phenylalanine motif. Full-length XRCC1-
His resulted in partial quenching of AC fluorescence at 490 nm
in a concentration-dependent manner (Fig. 4A). Nonlinear
regression analysis of this binding data revealed unimodal bind-
ing with a Kd  30 nM for XRCC1-His, consistent with our
previous report (32), and Kd  95 nM for His-XRCC1161–406,
indicating3-foldweaker but nevertheless tight binding by the
latter (Fig. 4A). Importantly, mutation of the three phenylala-
nine residues in full-length XRCC1-His (His-XRCC1FFF)
induced only 4% 6-acryloyl-2-dimethylaminonaphthalene
(AC) quenching when added in 6-fold excess (Fig. 4B). This
level of quenching is too low to obtain a Kd, suggesting that the
phenylalanine motif is required for the low-affinity interaction
with PNKP-AC.
To examine the phenylalanine motif for interaction with
PNKP in cells we co-transfected EM9 cells with constructs
encoding human PNKP and either wild-type full-length
XRCC1-His or mutant full-length XRCC1-HisFFF, and affinity
purified His-tagged protein complexes by metal-chelate chro-
Figure 1. Anovel conserveddomain inXRCC1. Shown is a schematic of establishedmolecular interaction sites in humanXRCC1. A highly conserveddomain
of40 amino acids located between the NTD and the NLS and containing three invariant phenylalanine residues (underlined) including a putative RIR motif
(boxed), is highlighted. Hs, Homo sapiens;Mm,Mus musculus; XL, Xenopus laevis; Dm, Drosophila melanogaster.
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matography (Fig. 4C). Similar amounts of PNKP co-purified
with either XRCC1-His protein, suggesting that mutation of
the phenylalaninemotif did not greatly reduce XRCC1 interac-
tion with PNKP. This was not surprising, because cellular
XRCC1 is constitutively phosphorylated by CK2 and thus can
bind PNKP via the high-affinity interaction. Indeed, as reported
previously (4, 18), mutation of the CK2 phosphorylation sites
that mediate the high-affinity interaction greatly reduced
PNKP co-precipitation (Fig. 4C, XRCC1-HisS518A/T519A/T523A).
Importantly, however, overexposure of the autoradiograph
revealed a small amount of residual co-purified hPNKP, which
was further reduced or ablated by additional mutation of the
phenylalanine motif (Fig. 4C, right). Together, these data sug-
gest thatwhereas the PNKP interaction is determined primarily
by the high-affinity phosphorylation-dependent interaction,
the low-affinity interaction is disrupted bymutation of the phe-
nylalanine motif.
XRCC1 stimulates PNKP activity if the latter is present at a
limiting concentration (3, 4, 30, 32).We therefore examined the
impact of the phenylalaninemotif on PNKP activity, in vitro (3, 4,
32). Recombinant His-XRCC1161–406 stimulated the 5-DNA
kinase activity of PNKP almost to the same extent as full-length
XRCC1-His, and this stimulation was ablated by mutation of
the phenylalanine motif (Fig. 5A). This was not the case for
mutations in the BRCT I domain that binds poly(ADP-ribose)
(13, 14), which did not impact on PNKP stimulation (Fig. 5A,
His-XRCC1161–406-RK). Because PNKP stimulation by XRCC1
reflects the displacement of PNKP from its 5-phosphorylated
DNA product, enabling further rounds of enzyme activity (30,
32), we next conducted single turnover experiments in which
DNA substrate was present in 10-fold excess over PNKP. As
expected, DNA kinase activity plateaued at10% product for-
mation, and subsequent addition of full-length XRCC1-His
promoted further activity (Fig. 5B). In contrast, XRCC1-HisFFF
was unable to stimulate PNKP, consistent with an inability to
interact with PNKP and displace it from its 5-phosphorylated
DNA product (Fig. 5B). Notably, similar results were observed
for DNA phosphatase activity, suggesting that the phenylala-
Figure 2. The RIR motif is important for XRCC1-dependent cell survival following oxidative stress. A, clonogenic survival of XRCC1-mutant EM9 cells
stably transfected with empty pCD2E vector (V) or with pCD2E expression constructs encoding full-length wild-type XRCC1-His (EM9-XH) or XRCC1-HisFFF
(EM9-XHFFF). Cells were treated with the indicated concentrations of H2O2 for 15min and then in drug-freemedium for 10–14 days to allow colony formation.
Data are the mean S.E. of three independent experiments. Where not visible, error bars are smaller than the symbols. B, clonogenic cell survival following
MMS treatment, as above.
Figure 3. TheRIRmotif is important for XRCC1-dependent SSBR followingoxidative stress.A, chromosomal SSBR ratesweremeasured in the above EM9
cell lines in alkaline comet assays following treatment with 150MH2O2 for 20min on ice, followed by recovery in drug-freemedium for the indicated time at
37 °C. B, steady state SSB levels as an indicator of chromosomal SSBR rates were measured in the above EM9 cell lines in alkaline comet assays following
treatment with the indicated concentration of MMS for 15 min at 37 °C. Data are the mean S.E. of three independent experiments.
RIRmotif in protein XRCC1mediates low-affinity interaction
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ninemotif is required for stimulation of both activities of PNKP
(Fig. 5C). Finally, because XRCC1 displaces PNKP from its
DNA product in part by direct competition for DNA we also
examined the influence of the phenylalanine motif on DNA
binding (Fig. 5D). XRCC1-His bound an oligodeoxyribonucle-
otide duplex harboring a single-nucleotide gap 5-fold more
tightly than did XRCC1-HisFFF (Kd 55 and250 nM, respec-
tively), suggesting that the phenylalanine motif also influences
binding to DNA.
Discussion
XRCC1 is a molecular scaffold protein that interacts with
multiple components of the SSBR pathway including Pol ,
PNKP, APTX, Aprataxin- and PNKP-like factor, and Lig3 (36,
37). The interaction with PNKP is likely to be particularly
important, because most of the DNA strand breaks induced by
oxidative damage to deoxyribose possess 3-phosphate moi-
eties and thus are substrates for the DNA phosphatase activity
of PNKP (20, 38, 39). In addition, SSBs arising from abortive
activity of topoisomerase I possess not only 3-phosphate ter-
mini but also 5-hydroxyl termini, which are substrates for the
DNA kinase activity of PNKP. XRCC1 interacts with PNKP via
a high-affinity (Kd,3.5 nM) phosphorylation-dependent inter-
action (4) and a lower affinity (Kd, 30 nM) phosphorylation-
independent interaction (4, 30, 32). Although the high-affinity
interaction iswell characterized, occurring via the FHAdomain
in PNKP and the CK2 phosphorylation sites located at Ser518/
Thr519/Thr523 in XRCC1, the site of the low-affinity interaction
Figure 4. The RIR motif mediates the phosphorylation-independent interaction with PNKP. A, phosphorylation-independent interaction of PNKP with
full-length and truncated XRCC1. Acrylodan-labeled PNKPwas excited at 380 nm, the relative fluorescence intensities weremonitored at 485 nm (the data for
XRCC1-His is provided in the inset) as a function of full-length XRCC1-His (f) or truncated His-XRCC1161–406 (●). The concentrations of PNKP-AC used were 20
and 80 nM with full-length XRCC1, and truncated His-XRCC1161–406, respectively. A representative plot of the fraction of PNKP-AC bound versus XRCC1
concentration is shown. The Kd values reported represents the mean S.E. (n 3). B, mutation of the phenylalanine motif prevents phosphorylation-inde-
pendent interaction of XRCC1with PNKP, in vitro. PNKP-AC (80 nM) was excited at 380 nm, and the emission fluorescencewasmeasured between 400 and 550
nm. Note that the emission peak was 490 nm and was quenched only by wild-type XRCC1 and not by His-XRCC1FFF mutant. Data are based on three
experiments using varied concentrations of the triplemutant. The scans shown represent data for a 1:1molar ratio for PNKP towild-typeXRCC1anda1:6molar
ratio of PNKP to XRCC1FFF. C, cell extract from EM9 cells transiently transfected with pcD2E-PNKP and either empty pcD2E vector (EM9-V) or a pCD2E expression
construct encoding full-length XRCC1-His (EM9-XH), XRCC1-HisFFF (EM9-XHFFF), XRCC1-HisS518A/T519A/T523A (EM9-XHS518A/T519A/T523A), or XRCC1-HisFFF/S518A/T519A/T523A
(EM9-XHFFF/518) was incubated with nickel-nitrilotriacetic acid-agarose and histidine-tagged protein complexes recovered as described under “Experimental proce-
dures.” Aliquots of the column input andeluatewere fractionatedby SDS-PAGEand immunoblottedwith anti-XRCC1 andanti-PNKP antibody. Thegel on the right is
an overexposure of the PNKP blot in the eluate sample.
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is unclear. Here, we show that the low-affinity site is encoded by
a highly conserved but poorly characterized region of XRCC1
containing three invariant phenylalanine residues (Phe172/
Phe192/Phe193). Two of the three phenylalanine residues are
components of a putative RIR motif; a protein interaction
domain that binds Rev1 and is present in multiple translesion
DNA polymerases (35). As expected, loss of the high-affinity
interaction had a much greater impact on the co-immunopre-
cipitation of cellular PNKP by XRCC1 than did loss of the low-
affinity interaction. However, loss of both interactions ablated
detectable co-immunoprecipitation of cellular XRCC1 and
PNKP in our experiments, suggesting that both interactions are
functional. The presence of two PNKP interaction sites in
XRCC1 is intriguing. We suggest a bipartite interaction model
in which the high-affinity interaction acts as a molecular tether
that promotes PNKP recruitment at SSBs and additionally
increases the likelihood of the low-affinity interaction, which in
turn stimulates PNKP directly (Fig. 6). Consistent with this,
mutation of the phenylalanine motif prevented the stimulation
of PNKP by XRCC1 in vitro. Interestingly, residue Ala482 has
also been reported to impact the phosphorylation-independent
interaction with PNKP (40). However, this residue is located
close to the phosphorylation-dependent site at 518/519/523,
and so it is currently unclear how this site relates to the site
reported here.
The data presented here indicate that the RIR motif is func-
tionally important for DNA strand break repair rates and cell
Figure 5. The conserved XRCC1 phenylalaninemotif is required for the phosphorylation-independent stimulation of PNKP activity. A, stimulation of
PNKP DNA kinase activity. 0.5M PNKPwas incubated in the presence of [-32P]ATP with 10M oligonucleotide substrate and 4M XRCC1-His, XRCC1-HisFFF,
His-XRCC1161–406, or His-XRCC1161–406-RK for 2min at 37 °C. The amount of radiolabeled 5-phosphorylated 24-mer oligonucleotidewas then quantified by gel
electrophoresis and autoradiography. Data are the mean  S.D. of three independent experiments. B, stimulation of PNKP DNA kinase enzyme-product
turnover. DNA kinase reactions (50 l) containing 2 M 1-nt gapped oligonucleotide substrate and 0.2 M PNKP were conducted as above in the absence of
XRCC1 for 20 min and XRCC1-His or XRCC1-HisFFF then added to 0.8 M for a further 20 min. Phosphorylated oligonucleotide product was quantified at the
indicated times, as above. Data are the mean S.D. of three independent experiments. C, stimulation of PNKP DNA phosphatase activity. DNA phosphatase
reactions (30l) containing 0.33M 1-nt gapped oligonucleotide substrate and 0.86M PNKPwere incubated in the absence of any XRCC1 protein for 20min
and then,where indicated, in theadditional presenceof 1.65MXRCC1-His orXRCC1-HisFFF for a further 20min. 3-Dephosphorylatedoligonucleotideproduct
was quantified at the indicated times, as above. Data are themean S.D. of three independent experiments.D, Interaction of XRCC1-His (f) and XRCC1-HisFFF
(●)with 1-nt gappedDNA. Proteins (30nM)were excited at 295nmand the fluorescence intensity at 340nmwasmonitored as a functionof added1nt-gapped
DNA substrate (see inset for data with XRCC1-His). The fraction bound, i.e. relative fluorescence (Rel. Fluor.), versus ligand concentration is plotted.
Figure 6. A model for a bipartite interaction between XRCC1 and PNKP.
Shown is a schematic depicting theproteindomains inXRCC1andPNKP,with
the regions of XRCC1 that are involved in the high-affinity and low-affinity
interactions amplified to illustrate the protein sequence. Note that the high-
affinity interaction site is mediated by the CK2 phosphorylation sites located
in XRCC1 at Ser518/Thr519/Thr523 (residues in red bold and associated phos-
phates indicated by red circles) and the phosphopeptide-binding FHA
domain of PNKP. The low-affinity interaction is mediated by a region span-
ning Phe173/Phe191/Phe192 (red bold). Note that Phe191/Phe192 form part of a
putative RIR motif (underlined).
RIRmotif in protein XRCC1mediates low-affinity interaction
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survival following oxidative stress. However, it is currently
unclear to what extent the interaction with PNKP accounts for
this importance, because thismotif also interactswithRev1 (35)
and with SSRP1 (41), a component of the FACT chromatin
remodeling complex. Further work is required to compare
directly the relative affinities of the XRCC1 RIR motif for the
three binding partners, but the data available to date suggest
that the affinity of XRCC1 for Rev1 in vitro is150-fold lower
than its affinity for PNKP (Kd of 5 M and 30 nM, respectively).
Interestingly, in contrast to its impact on oxidative DNA dam-
age, mutation of the RIR motif did not greatly impact the DNA
base excision repair rates or survival following DNA alkylation.
This is surprising because SSRP1 is implicated in the repair of
such damage. This result also suggests that relatively few PNKP
substrates arise during the excision repair of alkylated DNA
bases, and is consistent with MMS-induced SSBs arising as
products of AP endonuclease-1 activity, which does not create
SSB termini that are substrates for PNKP.
In summary, we have identified within XRCC1 the site of a
phosphorylation-independent interaction with PNKP and
demonstrated the importance of this site for PNKP stimulation
and for normal rates of SSBR and cell survival following oxida-
tive stress. We propose that whereas the high-affinity interac-
tion acts as a molecular tether to ensure XRCC1 and PNKP are
in close proximity at SSBs arising globally across the genome,
the lower-affinity interaction is important to stimulate PNKP
activity, directly.
Experimental procedures
DNA expression constructs
The mammalian expression constructs pCD2E (empty vec-
tor) (42), pCD2E-PNK (encoding full-length PNKP) (4, 18), and
pCD2E-XH (encoding full-length XRCC1-His) (11) have been
described previously. pCD2E-XHFFF (encoding full-length
XRCC1-HisF173A/F191A/F192A in which the low-affinity PNKP-
binding site is mutated) was created by using a QuikChange site-
directed mutagenesis kit (Agilent Technologies). The bacterial
expression constructs pET16b-PNK (encoding full-length N-ter-
minally tagged His-PNKP) (23), pET16b-XH (encoding full-
lengthXRCC1-His) (11), pTWO-E-His-XRCC1161–406 (encoding
the truncatedXRCC1proteinHis-XRCC1161–533) (14), andpTWO-
E-His-XRCC1161–406-RK (encoding the truncated XRCC1 protein
His-XRCC1161–533 R335A/K369A in which the poly(ADP-ribose)-
binding domain is mutated) (14) have been described previously.
pET16b-HXFFF (encoding full-length His-XRCC1F173A/F191A/F192A
in which the low-affinity PNKP-binding site is mutated) was cre-
ated by PCR, subcloning into pCR2.1-TOPO, and finally subclon-
ing into the NdeI site of pET16b (Novagen). All subcloned
sequences were verified by Sanger sequencing.
Recombinant proteins
His-PNKP was expressed from pET16b-PNK, purified, and
labeled with AC as previously described (23, 32). Histidine-
tagged XRCC1 proteins were expressed from the bacterial
expression constructs indicated above and purified as previ-
ously described (43).
Clonogenic survival assays
500 cells each cell type were plated in duplicate in 10-cm
dishes and incubated for 4 h at 37C. Cells were rinsedwith PBS
and eithermock treated or treated withH2O2 (diluted in PBS at
the indicated concentration immediately prior to use) or MMS
(diluted in complete medium at the indicated concentration
immediately prior to use) for 15 min at room temperature
(H2O2) or 37 °C (MMS). After treatment, cells were washed
twice with PBS and incubated for 10–14 days in drug-free
medium at 37 °C to allow formation of macroscopic colonies.
Colonies were fixed in ethanol (95%), stained with 1% methyl-
ene blue in 70% ethanol, and colonies of 50 cells were
counted. Percentage survival was calculated for each drug
concentration using the equation: 100 [average mean col-
ony number (treated plate)/average mean colony number
(untreated plate)].
Alkaline single cell-agarose gel electrophoresis (alkaline
comet assay)
Subconfluent cell monolayers were trypsinized, diluted to
2 105 cells/ml in ice-cold PBS (for H2O2 treatment) or com-
plete media (for MMS treatment) immediately prior to treat-
ment, and either mock-treated or treated with 150 M H2O2
(diluted in ice-cold PBS immediately prior to use) for 20min on
ice or with the indicated concentration of MMS (diluted in
completemedium) for 15min at 37 °C.Cellswere then rinsed in
ice-cold PBS and incubated, where appropriate, in fresh drug-
free media for the desired repair period at 37 °C. Cells (100 per
data point) were then analyzed by alkaline comet assay as pre-
viously described (44) using Comet Assay IV software (Percep-
tive Instruments).
Steady-state fluorescence assays
Steady-state fluorescence spectra were measured at 25 °C on
a PerkinElmer Life Sciences LS-55 spectrofluorometer using
5-nm spectral resolution for excitation and emission using
10–100 nM acrylodan-labeled PNKP protein solutions as
described in our earlier studies (32). In DNA binding experi-
ments, PNKP was excited at 295 nm and changes in fluores-
cence were monitored at the emission maximum (340 nm). In
the case of 6-acryloyl-2-dimethylaminonaphthalene-labeled
PNKP protein (referred to as PNKPWFX402-AC in which all the
Trp exceptTrp402 located near theDNA-binding site have been
replaced by Phe), excitation was at 380 nm, and the changes in
AC fluorescence at the emission maximum (490 nm) were
monitored. Quantitative data for the binding of DNA ligands to
PNKPwere obtained bymeasuring the quenching of the intrin-
sic Trp fluorescence of the protein at 340 nm following excita-
tion at 295 nm as a function of DNA concentration. Fluores-
cence data were analyzed using GraphPad Prism software, as
described previously (43).
DNA kinase assays
PNKP (10 pmol) was premixed with 40 pmol of full-length
XRCC1-His, His-XRCC1FFF, His-XRCC1161–406, or His-
XRCC1161–406 R335A/K369A at 37 °C for 5 min and then the mix-
tures were added to 20-l (total volume) reactions containing
RIRmotif in protein XRCC1mediates low-affinity interaction
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kinase buffer (80mM succinic acid, pH 5.5, 10mMMgCl2, and 1
mM dithiothreitol), 0.2 nmol of 24-mer 5-DNA kinase sub-
strate (Integrated DNA Technologies; the single- and double-
stranded DNA substrates used in this study have been
described previously (32)) and 3.3 pmol of [-32P]ATP
(PerkinElmer Life Sciences) and incubated for 2 min at 37 °C.
4-l aliquotsweremixedwith 2l of 3 sequencing gel loading
dye (Fisher), boiled for 10 min, and fractionated on a 12% poly-
acrylamide, 7 M urea sequencing gel at 200 V. Gels were imaged
on a Typhoon 9400 variable mode imager (GE Healthcare,
Bucks, UK) and quantified using ImageQuant 5.2 software (GE
Healthcare).
PNKP-product turnover assays
The stimulation of PNKP DNA kinase-product turnover by
XRCC1 wasmeasured essentially as described (32). Briefly, 3
50-l reactions containing kinase buffer (80 mM succinic acid,
pH5.5, 10mMMgCl2, and 1mMdithiothreitol), 0.1 nmol of 1-nt
gapped DNA substrate (Integrated DNA Technologies; see
above), 0.2 nmol of unlabeled ATP, 3.3 pmol of [-32P]ATP
(PerkinElmer Life Sciences), and 10 pmol of PNKP were incu-
bated at 37 °C. From one of the reaction mixtures 4-l samples
were taken at 0, 1, 2, 5, 10, 20, and 30min. To the other reaction
mixtures 40 pmol of full-length wild-type XRCC1-His or His-
XRCC1FFF was added after 20min incubation and 4-l samples
taken after an additional 1, 2, 5, 10, 20, and 30min. The samples
weremixedwith 2l of 3 sequencing gel loading dye (Fisher),
boiled for 10 min, and fractionated on a 12% polyacrylamide, 7
M urea sequencing gel at 200 V. Gels were scanned on a
Typhoon 9400 variable mode imager and the resulting bands
were quantified using ImageQuant 5.2 software.
The stimulation of PNKP DNA phosphatase-product turn-
over by XRCC1 was measured as follows. To prepare the
3-DNAphosphatase substrate, 40 pmol of 1-nt gapped 45-mer
duplex substrate (32) harboring a 20-mer with a 3-phosphate
terminus at the gap was radiolabeled at the 5-terminus in a
50-l reaction with T4 PNK (3-phosphatase free)(New England
Biolabs) in the presence of [-32P]ATP (Perkin Elmer Life Sci-
ences). TheT4PNKwas then heat inactivated and the substrate
re-annealed by cooling. Each of 3  12-l aliquots of radiola-
beled substrate (each containing 10 pmol of substrate) was
incubated with 16 fmol of PNKP in a 30-l total volume in 1
T4 PNK buffer (New England Biolabs; 70 mM Tris, pH 7.6, 10
mM MgCl2, and 5 mM DTT) at 37 °C. 4-l samples were taken
fromoneof the three parallel reactions at 0, 1, 2, 5, 10, 20, and 30
min. To the other two reactions, 50 pmol of either XRCC1-His
or His-XRCC1FFF was added after 20 min and 4-l samples
were taken after a further 1-, 2-, 5-, 10-, and 20-min incubation.
Samples weremixedwith 2l of 3 sequencing gel loading dye
(Fisher), boiled for 10min, and fractionated on a 12% polyacryl-
amide sequencing gel containing 7Murea at 1800V for 3 h.Gels
were scanned and imaged as described above.
Affinity purification of histidine-tagged XRCC1 protein
complexes
Histidine-tagged XRCC1 protein complexes were affinity
purified essentially as described (18). Briefly, EM9 cells were
transiently transfected with pCD2E-PNK and either empty
pCD2E or the indicated pcD2E-XRCC1 expression construct
and after selection in G418 for 4 days re-suspended in lysis
buffer (25 mM HEPES, pH 8.0, 325 mM sodium chloride, 0.5%
Triton X-100, 10% glycerol, 1 mM dithiothreitol, 25 mM imid-
azole, 1/100 dilution of mammalian protease inhibitor mixture
(Sigma)) at a density of 1.25 106 cells/ml and incubated on ice
for 20 min. High-molecular-weight DNA was sheered by two
short bursts (5 s) of sonication and the cell extracts were clari-
fied by centrifugation. XRCC1-His complexes were purified by
metal-chelate affinity chromatography by incubation of cell
extract (0.3 ml) with 0.1 ml (0.05 ml bed volume) of nickel-
nitrilotriacetic acid-agarose (Qiagen) for 20 min on ice with
frequent mixing. The agarose beads were pelleted by gentle
centrifugation at 4 °C in a microcentrifuge (3000 rpm),
unbound material was removed, and the pellets were washed
five times with lysis buffer before eluting bound proteins in 0.3
ml of lysis buffer containing 250 mM imidazole.
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